United States Cat Allergy in Human Market valuation $1.19 billion by 2032 - Exclusive Report by DatamIntelligence

"The Global Cat Allergy in Human Market reached US$ 0.73 billion in 2023 and is expected to reach US$ 1.19 billion by 2032, growing at a CAGR of 5.6% during the forecast period 2024-2032." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/cat-allergy-in-human-market?sp

United States: Recent Industry Developments

✅ In September 2025, ALK-Abelló launched a next-generation sublingual immunotherapy for cat allergy patients, improving symptom control and patient adherence. The therapy targets long-term immune tolerance and quality of life.

✅ In August 2025, Regeneron Pharmaceuticals expanded clinical trials for monoclonal antibody treatments aimed at reducing IgE-mediated reactions in cat allergy sufferers. The research focuses on severe and persistent cases.

✅ In July 2025, Viaskin Therapeutics introduced patch-based immunotherapy for cat allergy, offering convenient, non-invasive treatment options for children and adults. The innovation supports gradual desensitization.

✅ In June 2025, Pfizer invested in R&D for novel biologics targeting cat allergen proteins, aiming to reduce inflammation and respiratory symptoms. The initiative strengthens the U.S. allergy therapeutic pipeline.

Japan: Recent Industry Developments

✅ In September 2025, Tanabe Mitsubishi Pharma launched sublingual cat allergy treatments optimized for Japanese patients, improving tolerability and long-term symptom relief. The therapy supports personalized allergy management.

✅ In August 2025, Chugai Pharmaceutical initiated clinical trials for monoclonal antibodies targeting cat allergens, focusing on safe and effective symptom reduction. The program advances Japan's biologic allergy treatments.

✅ In July 2025, Otsuka Pharmaceutical developed innovative immunotherapy patches for cat allergy, providing a non-invasive, convenient alternative for allergy sufferers. The approach enhances adherence and comfort.

✅ In June 2025, Astellas Pharma invested in research to create novel allergy therapeutics targeting cat allergens, integrating advanced molecular and immune-modulating technologies. The initiative promotes safer and more effective treatments.

Cat Allergy in Human Market: Drivers

Cat allergy in humans is an immune system reaction triggered by proteins found in a cat's skin cells, saliva, or urine. When sensitive individuals are exposed to these allergens, their immune system mistakenly identifies them as harmful invaders, releasing histamines and other chemicals that cause allergy symptoms. Common reactions include sneezing, runny or congested nose, itchy or watery eyes, coughing, wheezing, and in severe cases, asthma attacks. The allergen Fel d 1, primarily found in cat saliva and skin glands, is considered the most potent trigger for cat allergies.

The prevalence of cat allergy has increased with the rising number of households owning cats as pets. Environmental factors, such as indoor air quality and the presence of other allergens, can exacerbate symptoms. Management strategies include minimizing exposure by regular cleaning, using air purifiers, restricting cat access to certain areas, and washing hands or clothes after contact. Medications like antihistamines, decongestants, or corticosteroids can help control symptoms, while allergy immunotherapy (allergy shots) may provide long-term relief in some cases. Research continues into developing hypoallergenic cat breeds and targeted therapies to reduce allergen impact.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cat-allergy-in-human-market?sp

Cat Allergy in Human Market: Major Players

ANGANY Inc. among others.

Segment Covered in the Cat Allergy in Human Market:

➥ By Treatment Type: Antihistamines, Corticosteroids, Nasal Decongestants, Leukotriene Antagonists, Others

➥ By Route of Administration: Oral, Nasal, Parenteral

➥ By Mode of Prescription: Over-the-Counter, Prescription Based

➥ By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others

Research Process:

Both primary and secondary data sources have been used in the Cat Allergy in Human Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Cat Allergy in Human Market Research Industry:

➠ Who leads the Cat Allergy in Human industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Cat Allergy in Human market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Cat Allergy in Human market growth?
➠ What are the dominant sales and distribution strategies in the Cat Allergy in Human industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=cat-allergy-in-human-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.